| Year |
Citation |
Score |
| 2023 |
Read ML, Brookes K, Zha L, Manivannan S, Kim J, Kocbiyik M, Fletcher A, Gorvin CM, Firth G, Fruhwirth GO, Nicola JP, Jhiang S, Ringel MD, Campbell MJ, Sunassee K, et al. Combined Vorinostat and Chloroquine Inhibit Sodium Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37921808 DOI: 10.1158/1078-0432.CCR-23-2043 |
0.368 |
|
| 2021 |
Jhiang SM, Sipos JA. NIS in non-thyroidal tissues and impact on thyroid cancer therapy. Endocrine-Related Cancer. PMID 33974556 DOI: 10.1530/ERC-21-0035 |
0.403 |
|
| 2020 |
Jhiang SM, Konda B, Sipos JA, Nabhan F. Prospects for Re-differentiating Agents in the Use of Radioactive Iodine Therapy for Thyroid Cancer. Thyroid : Official Journal of the American Thyroid Association. PMID 32106791 DOI: 10.1089/Thy.2020.0143 |
0.397 |
|
| 2019 |
Liu J, Dong S, Wang H, Li L, Ye Q, Li Y, Miao J, Jhiang S, Zhao J, Zhao Y. Two distinct E3 ligases, SCF and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201900415R. PMID 31238008 DOI: 10.1096/Fj.201900415R |
0.471 |
|
| 2019 |
Robb R, Yang L, Shen C, Wolfe A, Webb A, Zhang X, Vedaie M, Saji M, Jhiang SM, Ringel MD, Williams TM. Inhibiting BRAF Oncogene-Mediated Radioresistance Effectively Radiosensitizes BRAF Mutant Thyroid Cancer Cells by Constraining DNA Double-strand Break Repair. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31097454 DOI: 10.1158/1078-0432.Ccr-18-3625 |
0.402 |
|
| 2019 |
Hurst Z, Liyanarachchi S, He H, Brock P, Sipos JA, Nabhan F, Kebebew E, Green P, Cote GJ, Sherman SI, Walker CJ, Chang YS, Xue S, Hollingsworth B, Li W, ... ... Jhiang SM, et al. Risk Haplotypes Uniquely Associated with Radioiodine Refractory Thyroid Cancer Patients of High African Ancestry. Thyroid : Official Journal of the American Thyroid Association. PMID 30654714 DOI: 10.1089/Thy.2018.0687 |
0.336 |
|
| 2018 |
Feng F, Yehia L, Ni Y, Chang YS, Jhiang SM, Eng C. A non-pump function of sodium iodide symporter in thyroid cancer via crosstalk with PTEN signaling. Cancer Research. PMID 30217930 DOI: 10.1158/0008-5472.Can-18-1954 |
0.513 |
|
| 2018 |
Kotlarek M, Kubiak A, Czetwertyńska M, Świerniak M, Gierlikowski W, Kolanowska M, Bakuła-Zalewska E, Jhiang SM, Jażdżewski K, Wójcicka A. The rs2910164 Genetic Variant of miR-146a-3p Is Associated with Increased Overall Mortality in Patients with Follicular Variant Papillary Thyroid Carcinoma. International Journal of Molecular Sciences. 19. PMID 29495389 DOI: 10.3390/Ijms19030655 |
0.319 |
|
| 2017 |
Ashtekar A, Huk D, Magner A, La Perle K, Zhang X, Piruat J, Lopez-Barneo J, Jhiang S, Kirschner L. Sdhd ablation promotes thyroid tumorigenesis by inducing a stem-like phenotype. Endocrine-Related Cancer. PMID 28928232 DOI: 10.1530/Erc-17-0229 |
0.726 |
|
| 2017 |
Cheng P, Hollingsworth B, Scarberry D, Shen DH, Powell K, Smart SC, Beech J, Sheng X, Kirschner LS, Menq CH, Jhiang SM. Automated microSPECT/microCT image analysis of the mouse thyroid gland. Thyroid : Official Journal of the American Thyroid Association. PMID 28920557 DOI: 10.1089/Thy.2017.0264 |
0.638 |
|
| 2016 |
Hollingsworth B, Senter L, Zhang X, Brock GN, Jarjour W, Nagy R, Brock P, Coombes KR, Kloos R, Ringel MD, Sipos J, Lattimer I, Carrau R, Jhiang SM. Risk Factors of (131)I-Induced Salivary Gland Damage in Thyroid Cancer Patients. The Journal of Clinical Endocrinology and Metabolism. jc20161605. PMID 27533304 DOI: 10.1210/Jc.2016-1605 |
0.371 |
|
| 2015 |
Bible KC, Cote GJ, Demeure MJ, Elisei R, Jhiang S, Ringel MD. Correlative Studies in Clinical Trials: A Position Statement From the International Thyroid Oncology Group. The Journal of Clinical Endocrinology and Metabolism. 100: 4387-95. PMID 26418285 DOI: 10.1210/Jc.2015-2818 |
0.364 |
|
| 2015 |
Lakshmanan A, Scarberry D, Green JA, Zhang X, Selmi-Ruby S, Jhiang SM. Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin. Oncotarget. PMID 26397139 DOI: 10.18632/Oncotarget.5172 |
0.502 |
|
| 2015 |
Lakshmanan A, Wojcicka A, Kotlarek M, Zhang X, Jazdzewski K, Jhiang SM. microRNA-339-5p modulates Na+/I- symporter-mediated radioiodide uptake. Endocrine-Related Cancer. 22: 11-21. PMID 25404690 DOI: 10.1530/Erc-14-0439 |
0.317 |
|
| 2015 |
Lakshmanan A, Scarberry D, Green JA, Zhang X, Selmi-Ruby S, Jhiang SM. Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and Apigenin Oncotarget. 6: 31792-31804. DOI: 10.18632/oncotarget.5172 |
0.405 |
|
| 2014 |
Lakshmanan A, Scarberry D, Shen DH, Jhiang SM. Modulation of sodium iodide symporter in thyroid cancer. Hormones & Cancer. 5: 363-73. PMID 25234361 DOI: 10.1007/S12672-014-0203-0 |
0.684 |
|
| 2014 |
Lakshmanan A, Doseff AI, Ringel MD, Saji M, Rousset B, Zhang X, Jhiang SM. Apigenin in combination with Akt inhibition significantly enhances thyrotropin-stimulated radioiodide accumulation in thyroid cells. Thyroid : Official Journal of the American Thyroid Association. 24: 878-87. PMID 24400871 DOI: 10.1089/Thy.2013.0614 |
0.491 |
|
| 2013 |
La Perle KM, Kim DC, Hall NC, Bobbey A, Shen DH, Nagy RS, Wakely PE, Lehman A, Jarjoura D, Jhiang SM. Modulation of sodium/iodide symporter expression in the salivary gland. Thyroid : Official Journal of the American Thyroid Association. 23: 1029-36. PMID 23441638 DOI: 10.1089/Thy.2012.0571 |
0.819 |
|
| 2013 |
Zhang Z, Beyer S, Jhiang SM. MEK inhibition leads to lysosome-mediated Na+/I- symporter protein degradation in human breast cancer cells. Endocrine-Related Cancer. 20: 241-50. PMID 23404856 DOI: 10.1530/Erc-12-0342 |
0.64 |
|
| 2013 |
Lakshmanan A, Jhiang SM. Abstract 87: Apigenin further enhances Akti1/2-induced radioactive iodine uptake (RAIU) and rescues TGF-β1-reduced RAIU in PCCl3 rat thyroid cells. Cancer Research. 73: 87-87. DOI: 10.1158/1538-7445.Am2013-87 |
0.533 |
|
| 2012 |
Brandt MP, Kloos RT, Shen DH, Zhang X, Liu YY, Jhiang SM. Micro-single-photon emission computed tomography image acquisition and quantification of sodium-iodide symporter-mediated radionuclide accumulation in mouse thyroid and salivary glands. Thyroid : Official Journal of the American Thyroid Association. 22: 617-24. PMID 22540327 DOI: 10.1089/Thy.2011.0348 |
0.625 |
|
| 2012 |
Liu YY, Zhang X, Ringel MD, Jhiang SM. Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells. Endocrine-Related Cancer. 19: 291-304. PMID 22355179 DOI: 10.1530/Erc-11-0288 |
0.563 |
|
| 2011 |
Beyer SJ, Zhang X, Jimenez RE, Lee ML, Richardson AL, Huang K, Jhiang SM. Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer. Bmc Research Notes. 4: 397. PMID 21989294 DOI: 10.1186/1756-0500-4-397 |
0.438 |
|
| 2011 |
Beyer S, Lakshmanan A, Liu YY, Zhang X, Wapnir I, Smolenski A, Jhiang S. KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells. Endocrinology. 152: 782-92. PMID 21209020 DOI: 10.1210/En.2010-0782 |
0.511 |
|
| 2011 |
Liu YY, Brandt MP, Shen DH, Kloos RT, Zhang X, Jhiang SM. Single photon emission computed tomography imaging for temporal dynamics of thyroidal and salivary radionuclide accumulation in 17-allyamino-17-demothoxygeldanamycin-treated thyroid cancer mouse model. Endocrine-Related Cancer. 18: 27-37. PMID 20943721 DOI: 10.1677/Erc-10-0185 |
0.667 |
|
| 2010 |
Jhiang SM, Shah MH. Prospects for small interfering RNA therapeutics in thyroid cancer. Thyroid : Official Journal of the American Thyroid Association. 20: 1049-50. PMID 20883169 DOI: 10.1089/Thy.2010.1660 |
0.334 |
|
| 2009 |
Huang Y, Wan J, Cheng MC, Zhang Z, Jhiang SM, Menq CH. Three-axis rapid steering of optically propelled micro/nanoparticles. The Review of Scientific Instruments. 80: 063107. PMID 19566196 DOI: 10.1063/1.3156838 |
0.429 |
|
| 2009 |
Beyer SJ, Jimenez RE, Shapiro CL, Cho JY, Jhiang SM. Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer? Breast Cancer Research and Treatment. 115: 205-212. PMID 18500672 DOI: 10.1007/S10549-008-0059-5 |
0.47 |
|
| 2007 |
Knostman KA, Venkateswaran A, Zimmerman B, Capen CC, Jhiang SM. Creation and characterization of a doxycycline-inducible mouse model of thyroid-targeted RET/PTC1 oncogene and luciferase reporter gene coexpression. Thyroid : Official Journal of the American Thyroid Association. 17: 1181-8. PMID 18004977 DOI: 10.1089/Thy.2007.0224 |
0.743 |
|
| 2007 |
Vadysirisack DD, Chen ES, Zhang Z, Tsai MD, Chang GD, Jhiang SM. Identification of in vivo phosphorylation sites and their functional significance in the sodium iodide symporter. The Journal of Biological Chemistry. 282: 36820-8. PMID 17913707 DOI: 10.1074/Jbc.M706817200 |
0.788 |
|
| 2007 |
Knostman KA, McCubrey JA, Morrison CD, Zhang Z, Capen CC, Jhiang SM. PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer. Bmc Cancer. 7: 137. PMID 17651485 DOI: 10.1186/1471-2407-7-137 |
0.615 |
|
| 2007 |
Vadysirisack DD, Venkateswaran A, Zhang Z, Jhiang SM. MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner. Endocrine-Related Cancer. 14: 421-32. PMID 17639055 DOI: 10.1677/Erc.1.01263 |
0.801 |
|
| 2007 |
Knostman KAB, Jhiang SM, Capen CC. Genetic alterations in thyroid cancer: The role of mouse models Veterinary Pathology. 44: 1-14. PMID 17197619 DOI: 10.1354/Vp.44-1-1 |
0.312 |
|
| 2006 |
Vadysirisack DD, Shen DH, Jhiang SM. Correlation of Na+/I- symporter expression and activity: implications of Na+/I- symporter as an imaging reporter gene. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 182-90. PMID 16391203 |
0.815 |
|
| 2006 |
Sarquis MS, Weber F, Shen L, Broelsch CE, Jhiang SM, Zedenius J, Frilling A, Eng C. High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomas. The Journal of Clinical Endocrinology and Metabolism. 91: 262-9. PMID 16249278 DOI: 10.1210/Jc.2005-1880 |
0.444 |
|
| 2005 |
Morgenstern KE, Vadysirisack DD, Zhang Z, Cahill KV, Foster JA, Burns JA, Kloos RT, Jhiang SM. Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients. Ophthalmic Plastic and Reconstructive Surgery. 21: 337-44. PMID 16234694 DOI: 10.1097/01.Iop.0000179369.75569.A8 |
0.813 |
|
| 2005 |
Marsee DK, Vadysirisack DD, Morrison CD, Prasad ML, Eng C, Duh QY, Rauen KA, Kloos RT, Jhiang SM. Variable expression of coxsackie-adenovirus receptor in thyroid tumors: implications for adenoviral gene therapy. Thyroid : Official Journal of the American Thyroid Association. 15: 977-87. PMID 16187905 DOI: 10.1089/Thy.2005.15.977 |
0.809 |
|
| 2005 |
Zhang Z, Liu YY, Jhiang SM. Cell surface targeting accounts for the difference in iodide uptake activity between human Na+/I- symporter and rat Na+/I- symporter. The Journal of Clinical Endocrinology and Metabolism. 90: 6131-40. PMID 16105966 DOI: 10.1210/Jc.2005-0895 |
0.622 |
|
| 2004 |
Venkateswaran A, Marsee DK, Green SH, Jhiang SM. Forskolin, 8-Br-3',5'-cyclic adenosine 5'-monophosphate, and catalytic protein kinase A expression in the nucleus increase radioiodide uptake and sodium/iodide symporter protein levels in RET/PTC1-expressing cells. The Journal of Clinical Endocrinology and Metabolism. 89: 6168-72. PMID 15579773 DOI: 10.1210/Jc.2004-1414 |
0.824 |
|
| 2004 |
Knostman KA, Cho JY, Ryu KY, Lin X, McCubrey JA, Hla T, Liu CH, Di Carlo E, Keri R, Zhang M, Hwang DY, Kisseberth WC, Capen CC, Jhiang SM. Signaling through 3',5'-cyclic adenosine monophosphate and phosphoinositide-3 kinase induces sodium/iodide symporter expression in breast cancer. The Journal of Clinical Endocrinology and Metabolism. 89: 5196-203. PMID 15472226 DOI: 10.1210/Jc.2004-0907 |
0.804 |
|
| 2004 |
Miyagi E, Braga-Basaria M, Hardy E, Vasko V, Burman KD, Jhiang S, Saji M, Ringel MD. Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells Molecular Carcinogenesis. 41: 98-107. PMID 15378648 DOI: 10.1002/Mc.20042 |
0.407 |
|
| 2004 |
Aldred MA, Huang Y, Liyanarachchi S, Pellegata NS, Gimm O, Jhiang S, Davuluri RV, de la Chapelle A, Eng C. Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3531-9. PMID 15337802 DOI: 10.1200/Jco.2004.08.127 |
0.461 |
|
| 2004 |
Marsee DK, Venkateswaran A, Tao H, Vadysirisack D, Zhang Z, Vandre DD, Jhiang SM. Inhibition of heat shock protein 90, a novel RET/PTC1-associated protein, increases radioiodide accumulation in thyroid cells. The Journal of Biological Chemistry. 279: 43990-7. PMID 15302866 DOI: 10.1074/Jbc.M407503200 |
0.801 |
|
| 2004 |
Lin X, Fischer AH, Ryu KY, Cho JY, Sferra TJ, Kloos RT, Mazzaferri EL, Jhiang SM. Application of the Cre/loxP system to enhance thyroid-targeted expression of sodium/iodide symporter. The Journal of Clinical Endocrinology and Metabolism. 89: 2344-50. PMID 15126562 DOI: 10.1210/Jc.2003-031963 |
0.817 |
|
| 2004 |
Burns JA, Morgenstern KE, Cahill KV, Foster JA, Jhiang SM, Kloos RT. Nasolacrimal obstruction secondary to I(131) therapy. Ophthalmic Plastic and Reconstructive Surgery. 20: 126-9. PMID 15083081 DOI: 10.1097/01.Iop.0000117340.41849.81 |
0.354 |
|
| 2004 |
Lin X, Ryu KY, Jhiang SM. Cloning of the 5'-flanking region of mouse sodium/iodide symporter and identification of a thyroid-specific and TSH-responsive enhancer. Thyroid : Official Journal of the American Thyroid Association. 14: 19-27. PMID 15009910 DOI: 10.1089/105072504322783803 |
0.726 |
|
| 2004 |
Marsee DK, Shen DH, MacDonald LR, Vadysirisack DD, Lin X, Hinkle G, Kloos RT, Jhiang SM. Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomography. Cancer Gene Therapy. 11: 121-7. PMID 14730332 DOI: 10.1038/Sj.Cgt.7700661 |
0.782 |
|
| 2004 |
Shen DH, Marsee DK, Schaap J, Yang W, Cho JY, Hinkle G, Nagaraja HN, Kloos RT, Barth RF, Jhiang SM. Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy. Gene Therapy. 11: 161-9. PMID 14712300 DOI: 10.1038/Sj.Gt.3302147 |
0.796 |
|
| 2003 |
Barton KN, Tyson D, Stricker H, Lew YS, Heisey G, Koul S, de la Zerda A, Yin FF, Yan H, Nagaraja TN, Randall KA, Jin GK, Fenstermacher JD, Jhiang S, Ho Kim J, et al. GENIS: gene expression of sodium iodide symporter for noninvasive imaging of gene therapy vectors and quantification of gene expression in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 508-18. PMID 12946325 DOI: 10.1016/S1525-0016(03)00153-9 |
0.354 |
|
| 2003 |
Fischer AH, Taysavang P, Jhiang SM. Nuclear envelope irregularity is induced by RET/PTC during interphase. The American Journal of Pathology. 163: 1091-100. PMID 12937150 DOI: 10.1016/S0002-9440(10)63468-2 |
0.404 |
|
| 2003 |
Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C, Eng C. Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. Cancer Research. 63: 2864-71. PMID 12782592 |
0.424 |
|
| 2003 |
Aldred MA, Morrison C, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang S, Eng C. Peroxisome proliferator-activated receptor gamma is frequently downregulated in a diversity of sporadic nonmedullary thyroid carcinomas. Oncogene. 22: 3412-6. PMID 12776192 DOI: 10.1038/Sj.Onc.1206400 |
0.508 |
|
| 2003 |
La Perle KM, Blomme EA, Capen CC, Jhiang SM. Effect of exogenous human sodium iodide symporter expression on growth of MATLyLu cells. Thyroid : Official Journal of the American Thyroid Association. 13: 133-40. PMID 12699587 DOI: 10.1089/105072503321319431 |
0.749 |
|
| 2002 |
Kloos RT, Duvuuri V, Jhiang SM, Cahill KV, Foster JA, Burns JA. Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 87: 5817-20. PMID 12466391 DOI: 10.1210/Jc.2002-020210 |
0.311 |
|
| 2002 |
Buckwalter TL, Venkateswaran A, Lavender M, La Perle KM, Cho JY, Robinson ML, Jhiang SM. The roles of phosphotyrosines-294, -404, and -451 in RET/PTC1-induced thyroid tumor formation. Oncogene. 21: 8166-72. PMID 12444552 DOI: 10.1038/Sj.Onc.1205938 |
0.771 |
|
| 2002 |
Patel A, Jhiang S, Dogra S, Terrell R, Powers PA, Fenton C, Dinauer CA, Tuttle RM, Francis GL. Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents. Pediatric Research. 52: 737-44. PMID 12409522 DOI: 10.1203/00006450-200211000-00021 |
0.482 |
|
| 2002 |
Cho JY, Shen DH, Yang W, Williams B, Buckwalter TL, La Perle KM, Hinkle G, Pozderac R, Kloos R, Nagaraja HN, Barth RF, Jhiang SM. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas. Gene Therapy. 9: 1139-45. PMID 12170377 DOI: 10.1038/Sj.Gt.3301787 |
0.809 |
|
| 2002 |
La Perle KM, Shen D, Buckwalter TL, Williams B, Haynam A, Hinkle G, Pozderac R, Capen CC, Jhiang SM. In vivo expression and function of the sodium iodide symporter following gene transfer in the MATLyLu rat model of metastatic prostate cancer. The Prostate. 50: 170-8. PMID 11813209 DOI: 10.1002/Pros.10046 |
0.789 |
|
| 2001 |
Shen DHY, Kloos RT, Mazzaferri EL, Jhiang SM. Sodium iodide symporter in health and disease Thyroid. 11: 415-425. PMID 11396700 DOI: 10.1089/105072501300176372 |
0.543 |
|
| 2000 |
Jhiang SM. The RET proto-oncogene in human cancers Oncogene. 19: 5590-5597. PMID 11114739 DOI: 10.1038/Sj.Onc.1203857 |
0.419 |
|
| 2000 |
Rillema JA, Yu TX, Jhiang SM. Effect of prolactin on sodium iodide symporter expression in mouse mammary gland explants American Journal of Physiology - Endocrinology and Metabolism. 279. PMID 11001757 DOI: 10.1152/Ajpendo.2000.279.4.E769 |
0.377 |
|
| 2000 |
Cho JY, Léveillé R, Kao R, Rousset B, Parlow AF, Burak WE, Mazzaferri EL, Jhiang SM. Hormonal regulation of radioiodide uptake activity and Na+/I- symporter expression in mammary glands Journal of Clinical Endocrinology and Metabolism. 85: 2936-2943. PMID 10946907 DOI: 10.1210/Jcem.85.8.6727 |
0.691 |
|
| 2000 |
La Perle KM, Jhiang SM, Capen CC. Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas. The American Journal of Pathology. 157: 671-7. PMID 10934169 DOI: 10.1016/S0002-9440(10)64577-4 |
0.705 |
|
| 2000 |
Cho JY, Xing S, Liu X, Buckwalter TL, Hwa L, Sferra TJ, Chiu IM, Jhiang SM. Expression and activity of human Na+/I- symporter in human glioma cells by adenovirus-mediated gene delivery. Gene Therapy. 7: 740-9. PMID 10822300 DOI: 10.1038/Sj.Gt.3301170 |
0.801 |
|
| 1999 |
Castro MR, Bergert ER, Beito TG, Roche PC, Ziesmer SC, Jhiang SM, Goellner JR, Morris JC. Monoclonal antibodies against the human sodium iodide symporter: Utility for immunocytochemistry of thyroid cancer Journal of Endocrinology. 163: 495-504. PMID 10588823 DOI: 10.1677/Joe.0.1630495 |
0.323 |
|
| 1999 |
Cho JY, Sagartz JE, Capen CC, Mazzaferri EL, Jhiang SM. Early cellular abnormalities induced by RET/PTC1 oncogene in thyroid-targeted transgenic mice Oncogene. 18: 3659-3665. PMID 10380889 DOI: 10.1038/Sj.Onc.1202709 |
0.704 |
|
| 1999 |
Ryu KY, Senokozlieff ME, Smanik PA, Wong MG, Siperstein AE, Duh QY, Clark OH, Mazzaferri EL, Jhiang SM. Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter. Thyroid : Official Journal of the American Thyroid Association. 9: 405-9. PMID 10319949 DOI: 10.1089/Thy.1999.9.405 |
0.669 |
|
| 1998 |
Jhiang SM, Cho JY, Furminger TL, Sagartz JE, Tong Q, Capen CC, Mazzaferri EL. Thyroid carcinomas in RET/PTC transgenic mice Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 154: 265-270. PMID 10027006 DOI: 10.1007/978-3-642-46870-4_17 |
0.518 |
|
| 1998 |
Kosugi S, Sato Y, Matsuda A, Ohyama Y, Fujieda K, Inomata H, Kameya T, Isozaki O, Jhiang SM. High prevalence of T354P sodium/iodide symporter gene mutation in Japanese patients with iodide transport defect who have heterogeneous clinical pictures Journal of Clinical Endocrinology and Metabolism. 83: 4123-4129. PMID 9814502 DOI: 10.1210/Jcem.83.11.5229 |
0.376 |
|
| 1998 |
Jhiang SM, Cho JY, Ryu KY, DeYoung BR, Smanik PA, McGaughy VR, Fischer AH, Mazzaferri EL. An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues. Endocrinology. 139: 4416-9. PMID 9751526 DOI: 10.1210/Endo.139.10.6329 |
0.737 |
|
| 1998 |
Kosugi S, Inoue S, Matsuda A, Jhiang SM. Novel, missense and loss-of-function mutations in the sodium/iodide symporter gene causing iodide transport defect in three Japanese patients Journal of Clinical Endocrinology and Metabolism. 83: 3373-3376. PMID 9745458 DOI: 10.1210/Jcem.83.9.5243 |
0.357 |
|
| 1998 |
Ryu KY, Tong Q, Jhiang SM. Promoter characterization of the human Na+/I- symporter. The Journal of Clinical Endocrinology and Metabolism. 83: 3247-51. PMID 9745437 DOI: 10.1210/Jcem.83.9.5118 |
0.636 |
|
| 1998 |
Pohlenz J, Rosenthal IM, Weiss RE, Jhiang SM, Burant C, Refetoff S. Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3' splice site. The Journal of Clinical Investigation. 101: 1028-35. PMID 9486973 DOI: 10.1172/Jci1504 |
0.389 |
|
| 1998 |
Xing S, Furminger TL, Tong Q, Jhiang SM. Signal transduction pathways activated by RET oncoproteins in PC12 pheochromocytoma cells Journal of Biological Chemistry. 273: 4909-4914. PMID 9478934 DOI: 10.1074/Jbc.273.9.4909 |
0.398 |
|
| 1997 |
Tong Q, Ryu KY, Jhiang SM. Promoter characterization of the rat Na+/I- symporter gene. Biochemical and Biophysical Research Communications. 239: 34-41. PMID 9345265 DOI: 10.1006/Bbrc.1997.7432 |
0.649 |
|
| 1997 |
Smanik PA, Ryu KY, Theil KS, Mazzaferri EL, Jhiang SM. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology. 138: 3555-8. PMID 9231811 DOI: 10.1210/Endo.138.8.5262 |
0.659 |
|
| 1997 |
Sagartz JE, Jhiang SM, Tong Q, Capen CC. Thyroid-stimulating hormone promotes growth of thyroid carcinomas in transgenic mice with targeted expression of the ret/PTC1 oncogene Laboratory Investigation. 76: 307-318. PMID 9121114 |
0.385 |
|
| 1997 |
Tong Q, Xing S, Jhiang SM. Leucine zipper-mediated dimerization is essential for the PTC1 oncogenic activity Journal of Biological Chemistry. 272: 9043-9047. PMID 9083029 DOI: 10.1074/Jbc.272.14.9043 |
0.382 |
|
| 1996 |
Jossart GH, O'Brien B, Cheng JF, Tong Q, Jhiang SM, Duh Q, Clark OH, Weier HUG. A novel multicolor hybridization scheme applied to localization of a transcribed sequence (D10S170/H4) and deletion mapping in the thyroid cancer cell line TPC-1 Cytogenetics and Cell Genetics. 75: 254-257. PMID 9067436 DOI: 10.1159/000134495 |
0.34 |
|
| 1996 |
Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL, Jhiang SM. Cloning of the human sodium iodide symporter Biochemical and Biophysical Research Communications. 226: 339-345. PMID 8806637 DOI: 10.1006/Bbrc.1996.1358 |
0.688 |
|
| 1996 |
Xing S, Smanik PA, Oglesbee MJ, Trosko JE, Mazzaferri EL, Jhiang SM. Characterization of ret oncogenic activation in MEN2 inherited cancer syndromes Endocrinology. 137: 1512-1519. PMID 8612479 DOI: 10.1210/Endo.137.5.8612479 |
0.418 |
|
| 1996 |
Jhiang SM, Sagartz JE, Tong Q, Parker-thornburg J, Capen CC, Cho JY, Xing S, Ledent C. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas Endocrinology. 137: 375-378. PMID 8536638 DOI: 10.1210/Endo.137.1.8536638 |
0.462 |
|
| 1995 |
Smanik PA, Furminger TL, Mazzaferri EL, Jhiang SM. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma Human Molecular Genetics. 4: 2313-2318. PMID 8634704 DOI: 10.1093/Hmg/4.12.2313 |
0.433 |
|
| 1994 |
Jhiang SM, Smanik PA, Mazzaferri EL. Development of a single-step duplex RT-PCR detecting different forms of ret activation, and identification of the third form of in vivo ret activation in human papillary thyroid carcinoma Cancer Letters. 78: 69-76. PMID 8180971 DOI: 10.1016/0304-3835(94)90033-7 |
0.424 |
|
| 1994 |
Jhiang SM, Mazzaferri EL. The ret/PTC oncogene in papillary thyroid carcinoma Journal of Laboratory and Clinical Medicine. 123: 331-337. PMID 8133143 |
0.31 |
|
| 1994 |
Smanik PA, Fithian LJ, Jhiang SM. Thyroid Peroxidase Expression and DNA Polymorphisms in Thyroid Cancer Biochemical and Biophysical Research Communications. 198: 948-954. PMID 8117301 DOI: 10.1006/Bbrc.1994.1135 |
0.428 |
|
| 1994 |
Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer The American Journal of Medicine. 97: 418-428. PMID 7977430 DOI: 10.1016/0002-9343(94)90321-2 |
0.403 |
|
| 1993 |
Jhiang SM, Fithian L, Smanik P, McGill J, Tong Q, Mazzaferri EL. Cloning of the human taurine transporter and characterization of taurine uptake in thyroid cells1 1 The cDNA sequence of HTAU has been deposited in EMBL Febs Letters. 318: 139-144. PMID 8382624 DOI: 10.1016/0014-5793(93)80008-I |
0.385 |
|
| 1992 |
Jhiang SM, Caruso DR, Gilmore E, Ishizaka Y, Tahira T, Nagao M, Chiu IM, Mazzaferri EL. Detection of the PTC/retTPC oncogene in human thyroid cancers. Oncogene. 7: 1331-7. PMID 1620547 |
0.352 |
|
| 1988 |
Jhiang SM, Garey JR, Riggs AF. Exon-intron organization in genes of earthworm and vertebrate globins Science. 240: 334-336. PMID 2832953 |
0.594 |
|
| Show low-probability matches. |